AzTrials
AzTrials

Postoperative DeliriumNCT04736303

The Impact of the Implementation of BIS on the Incidence of Postoperative Delirium

A study testing BIS in people with Postoperative Delirium, run by University of Thessaly at 1 site in Greece.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will investigate the incidence of postoperative POD in patients undergoing non cardiac surgery under general anesthesia with and without the implementation of the BIS monitoring.T Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Postoperative Delirium
What is being tested?
BIS
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,400 participants
Where
1 siteGreece
Study dates
1 Dec 2021to 1 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult patients over 60 years of age
  • an American Society of Anesthesiologists (ASA) physical status I to III
  • undergoing elective non cardiac surgery under general anaesthesia
  • native speakers of the Greek language
  • eligible to leave the post-anaesthesia care unit
  • an expected in-hospital stay at least 24 hours following surgery

Who cannot join

  • refused to participate or sign the informed consent form
  • surgery or anaesthesia within the last 30 day
  • any prior or current history involving an affliction of the central nervous system
  • severe hearing or visual impairment
  • psychiatric disorders
  • a score less than 5 according the Geriatric Depression Scale (GDS-15)
Show all 12Show fewer
  • a score less than 4 for females and less than 2 for males according to the Lawton-Brody Instrumental Activities of Daily Living Scale (I.A.D.L.)
  • alcohol consumption less than 35 units/week
  • drug dependence
  • previous neuropsychological testing
  • haemodynamical instability
  • peri-procedural desaturation (one or more events of SpO2<80% for more than 2 minutes)

Trial locations and contacts

1 site in 1 country.

Eleni Arnaoutoglou, MD, PhD contact

+306974301352

earnaout@gmail.com

Maria Ntalouka, MD, PhD contact

+306973688099

maria.ntalouka@icloud.com

Greece1 site, 1 recruiting
  • Univeristy of Thessaly

    Larissa, Thessaly, 41110

    Eleni Arnaoutoglou, MD, PhD, 2413501370, earnaout@gmail.com

    Maria Ntalouka, MD, +306973688099, maria.ntalouka@icloud.com

    Recruiting

Other trials in Greece

About this study

Official title: Assessing the Impact of the Implementation of BIS on the Incidence of Postoperative Delirium - A Monocentre Prospective Trial

This study will investigate the incidence of postoperative POD in patients undergoing non cardiac surgery under general anesthesia with and without the implementation of the BIS monitoring.T

Read the detailed description

This study will compare the incidence of POD after elective non cardiac surgery conducted under general anesthesia before and after the implementation of BIS monitoring in our University Hospital.

The POD will be evaluated with the CAM and Nu-DESC tools, which have been adapted for the greek population.

Being tested
BIS
Medical subject headings
Emergence Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BISDevice

    The implementation of BIS monitoring

Study groups in NCT04736303
Study groupRoleWhat they receive
POD without BISNo interventionAssessing the incidence of POD in patients under general anethesia for elective non cardiac surgery, with CAM and Nu-DESC tools.
POD with BISActive comparatorAssessing the incidence of POD in patients under general anethesia for elective non cardiac surgery with the implementation of BIS monitoring, with CAM and Nu-DESC tools.
Receives: Device: BIS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of POD

    Assess the incidence of POD with CAM and Nu-DESC tools

    Measured: 1st postoperative day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2021
  2. Study start1 Dec 2021
  3. Primary completion30 Dec 2022 (estimated)
  4. Study completion1 Apr 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
1,400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04736303
Sponsor's protocol ID
POD and BIS
Status last verified
Aug 2022
First submitted
2 Oct 2020
Last updated
19 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing BIS in people with Postoperative Delirium, run by University of Thessaly at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Eleni Arnaoutoglou, MD, PhD (+306974301352, earnaout@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of POD (time frame: 1st postoperative day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in